Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-942-4 | CAS number: 5570-77-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity:
LD50 was estimated to be 3689 mg/kg bw when rats were orally exposed with 4-chloro-1-methylpiperidine.
Acute inhalation toxicity:
LC50 was estimated to be 27300 mg/m3when B6C3F1 male and female mice were inhaled by vapour using whole body for 4 hours.
Acute dermal toxicity:
LD50 was estimated to be 2018 mg/kg bw when New Zealand White male and female rabbits were treated with 4-chloro-1-methylpiperidine occlusive by dermal application.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 689 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from OECD QSAR toolbox
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 27 300 mg/m³ air
- Quality of whole database:
- Data is Klimisch 2 and from OECD QSAR toolbox
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 018 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from OECD QSAR toolbox
Additional information
Acute oral toxicity:
In different studies, 4-chloro-1-methylpiperidine has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in vivo experiments and estimations in rodents, i.e. most commonly in rats for 4-chloro-1-methylpiperidinealong with the study available on structurally similar read across substance 2-Chlorobutane (CAS no 78-86-4) and Ethanol, 2.2’-(methylimino)bis- (CAS no 105-59-9). The predicted data using the OECD QSAR toolbox has also been compared with the experimental studies.
In a prediction done by SSS (2017) using the OECD QSAR toolbox with log kow as the primary descriptor, the acute oral toxicity was estimated for 4-chloro-1-methylpiperidine. The LD50 was estimated to be 3689 mg/kg bw when rats were orally exposed with 4-chloro-1-methylpiperidine.
In another experimental study conducted by Smythet al (American Industrial Hygiene Association Journal, 30:5, 470-476, 1969) on structurally similar read across substance 2-Chlorobutane (CAS no 78-86-4), rat were treated with 2-Chlorobutane in the concentration of 17460 mg/kg bw orally. 50 % mortality observed in 17460 mg/kg bw treated rats. Therefore, LD50 was considered to be 17460 mg/kg bw (11174—27324) when rat were treated with 2-Chlorobutane orally.
This is further supported by experimental study summarize by European Chemicals Bureau (IUCID Data set, European Chemicals Bureau, 18–FEB–2000, 58) on structurally similar read across substance Ethanol, 2.2’-(methylimino)bis- (CAS no 105-59-9), five Carworth –Wistar rats were treated with Ethanol, 2.2’-(methylimino)bis- (MDEA) in the concentration in a logarithmic series. 50 % mortality observed in treated rats at 4780 mg/kg bw. Therefore, LD50 was considered to be 4780 mg/kg bw when Carworth–Wistar rats were treated with Ethanol, 2.2’-(methylimino)bis- (MDEA) orally by gavage.
Further this is supported by another experimental study summarize by European Chemicals Bureau (IUCID Data set, European Chemicals Bureau, 18–FEB–2000, 58) on structurally similar read across substance Ethanol, 2.2’-(methylimino)bis- (CAS no 105-59-9),rats were treated with Ethanol, 2.2’-(methylimino)bis- (MDEA) in the concentration of 4680 mg/kg bw. 50 % mortality observed in treated rats at 4680 mg/kg bw. Therefore, LD50 was considered to be 4680 mg/kg bw when rats were treated with Ethanol, 2.2’-(methylimino)bis- (MDEA) orally.
Thus, based on the above studies and predictions on 4-chloro-1-methylpiperidine and its read across substances, it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 4-chloro-1-methylpiperidine can be Not classified for acute oral toxicity.
Acute inhalation toxicity:
In different studies, 4-chloro-1-methylpiperidine has been investigated for acute inhalation toxicity to a greater or lesser extent. Often are the studies based on in vivo experiments and estimations in rodents, i.e. most commonly in mice and rats for 4-chloro-1-methylpiperidinealong with the study available on structurally similar read across substance 1-Methylpiperazine (CAS no: 109-01-3) and Chloromethane (CAS no: 74-87-3). The predicted data using the OECD QSAR toolbox has also been compared with the experimental studies.
In a prediction done by SSS (2017) using the OECD QSAR toolbox with log kow as the primary descriptor, the acute inhalation toxicity was estimated for 4-chloro-1-methylpiperidine. The LC50 was estimated to be 27300 mg/m3when B6C3F1 male and female mice were inhaled by vapour using whole body for 4 hours.
In another experimental study summarized by U.S. National Library of Medicine (ChemIDplus, A Toxnet Database, 2017) on structurally similar read across substance 1-Methylpiperazine (CAS no: 109-01-3), mice were inhaled with 2-Chlorobutane in the concentration of 2740 mg/m3. 50 % mortality observed at 2740 mg/m3 and Behavioral Excitement, Dyspnea Lungs, Thorax or Respiration and Muscle Contraction or Spasticity was observed in exposed mice. Therefore, LC50 was considered to be 2740 mg/m3when mice were inhaled with 1-Methylpiperazine.
This further supported by experimental study summarized by OECD SIDS (OECD SIDS, UNEP Publications, 19 March 2003) on structurally similar read across substance Chloromethane (CAS no: 74-87-3), mice were inhaled with Chloromethane in the concentration of 5300 mg/m3. 50 % mortality observed at 5300 mg/m3 in exposed rat. Therefore, LC50 was considered to be 5300 mg/m3 when rat were inhaled with Chloromethane for 4 hours.
Thus, based on the above studies and predictions on 4-chloro-1-methylpiperidine and its read across substances and by applying weight of evidence, it can be concluded that LC50 value is greater than 20 mg/m3. Thus, comparing this value with the criteria of CLP regulation, 4-chloro-1-methylpiperidine can be Not classified for acute inhalation toxicity.
Acute dermal toxicity:
In different studies, 4-chloro-1-methylpiperidine has been investigated for acute dermal toxicity to a greater or lesser extent. Often are the studies based on in vivo experiments and estimations in rodents, i.e. most commonly in mice and rats for 4-chloro-1-methylpiperidine along with the study available on structurally similar read across substance 2-Chlorobutane (CAS no 78-86-4) and Bis(trimethoxysilylpropyl)amine (CAS no 82985-35-1).The predicted data using the OECD QSAR toolbox has also been compared with the experimental studies.
In a prediction done by SSS (2017) using the OECD QSAR toolbox with log kow as the primary descriptor, the acute dermal toxicity was estimated for 4-chloro-1-methylpiperidine. The LD50 was estimated to be 2018 mg/kg bw when New Zealand White male and female rabbits were treated with 4-chloro-1-methylpiperidine occlusive by dermal application.
In another experimental study conducted by Smythet al (American Industrial Hygiene Association Journal, 30:5, 470-476, 1969) on structurally similar read across substance 2-Chlorobutane (CAS no 78-86-4), rabbits were treated with 2-Chlorobutane in the concentration of 17460 mg/kg bw orally. 50 % mortality was observed at 17460 mg/kg bw in treated rabbits. Therefore, LD50 was considered to be 17460 mg/kg bw when rabbits were treated with 2-Chlorobutane by single dermal application.
This further supported by experimental study summarized by Union Carbide Corp (NTRL, National Technical Information Service. Vol. OTS0533892, 1992) on structurally similar read across substance Bis(trimethoxysilylpropyl)amine (CAS no 82985-35-1),rabbits were treated with Bis(trimethoxysilylpropyl)amine by occlusive covering for 6 hours. 50 % mortality observed in treated male at 16640 mg/kg bw and at 11752mg/kg bw in female rabbitsand Lungs, Thorax or Respiration Changes, Somnolence (General Depressed Activity) and Dermatitis were observed in treated rabbits. Therefore,LD50 was considered to be 16640 mg/kg bw for male and 11752mg/kg bw in female when male and female rabbits were treated with Bis(trimethoxysilylpropyl)amine by single dermal application for 6 hours.
Thus, based on the above studies and predictions on 4-chloro-1-methylpiperidine and its read across substances, it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 4-chloro-1-methylpiperidine can be Not classified for acute dermal toxicity.
Justification for classification or non-classification
Based on the above studies and predictions on 4-chloro-1-methylpiperidine and its read across substances, it can be concluded that LD50 and LC50 value is greater than the classifing value . Thus, comparing this value with the criteria of CLP regulation, 4-chloro-1-methylpiperidine can be Not classified for acute oral, inhalation and dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.